Friday, October 31, 2008

Chair's Opening Remarks and Presentation SELECT Study Update Laurence H. Baker, D.O. Chair, Southwest Oncology Group and John J. Crowley, Ph.D. Director, Southwest Oncology Group Statistical Center

The NIH Chemical Genomics Center: Bringing Biopharmaceutical Technologies to Academic Chemical Probe and Drug Discovery Christopher P. Austin, M.D. Director, National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Rockville, Maryland

Correlation of PK, PD, Efficacy and Imaging in Pet Dogs with Naturally Occurring Lymphoma David M. Vail, D.V.M., Diplomate ACVIM (Oncology) Director, Center for Clinical Trials and Research, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin

Cancer Models: From Insight to Improved Care Terry Van Dyke, Ph.D. Director, Mouse Cancer Genetics Program, Director, Center for Advanced Preclinical Research, National Cancer Institute at Frederick, Sara Graham Kenan Distinguished Professor, Departments of Genetics and Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, Program in Molecular Biology and Biotechnology, University of North Carolina at Chapel Hill

Use of Pharmacokinetics, Pharmacogenetics, and Target Drug Delivery for Drug Development and Therapeutic Improvement (Not Available) Moses Sing Sum Chow, Pharm.D. Professor, Pharmacy Practice and Administration Department, College of Pharmacy, Director, Center for Advancement of Drug Research and Evaluation, Western University of Health Sciences, Pomona, California